Integra Lifesciences Holdings (IART) Total Current Liabilities (2009 - 2026)

Integra Lifesciences Holdings' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $346.8 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 62.24% year-over-year to $346.8 million; the TTM figure through Mar 2026 stood at $346.8 million (down 62.24% YoY), while the FY2025 annual figure was $456.0 million, down 50.55% from the prior year.
• Total Current Liabilities came in at $346.8 million for Q1 2026 at Integra Lifesciences Holdings, down from $456.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $929.8 million in Q2 2025 to a low of $282.3 million in Q1 2023.
• A 5-year average of $472.9 million and a median of $346.8 million in 2026 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 203.73% in 2025 and sank 62.24% in 2026, its largest moves.
• Integra Lifesciences Holdings' Total Current Liabilities stood at $320.9 million in 2022, then dropped by 4.34% to $307.0 million in 2023, then jumped by 200.39% to $922.1 million in 2024, then plunged by 50.55% to $456.0 million in 2025, then decreased by 23.93% to $346.8 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $346.8 million, $456.0 million, and $364.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison